SHR-A1403
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 28, 2022
A Study of SHR-A1403 in Patients With Advanced Solid Tumor
(clinicaltrials.gov)
- P1 | N=9 | Completed | Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Unknown status ➔ Completed | N=30 ➔ 9
Enrollment change • Trial completion • Oncology • Solid Tumor • MET
1 to 1
Of
1
Go to page
1